default author photo

Souad Assaad

University of Claude Bernard Lyon 1 - Medical Oncology Department

Lyon

France

  • University of Claude Bernard Lyon 1 - Medical Oncology Department

SCHOLARLY PAPERS

3

DOWNLOADS

158

TOTAL CITATIONS

0

Scholarly Papers (3)

Actions:
Email selected abstracts
1.

Survival and Incidence of COVID-19 After SARS-CoV-2 Vaccination in a Series of 2391 Cancer Patients

Number of pages: 22 Posted: 22 Nov 2021
Pierre Heudel, Bertrand Favier, Marie-Laure Solodky, Souad Assaad, Natacha Chaumard, Olivier Tredan, Thomas Bachelot, Isabelle-Laure Ray-Coquard, Bruno Russias, Marie-Line Fournier, Benedicte Mastroianni, Virginie Avrillon, Anne-Sophie Michallet, Philippe Zrounba, Sylvie Chabaud, David Pérol and Jean-Yves Blay
University of Claude Bernard Lyon 1 - Medical Oncology Department, University of Claude Bernard Lyon 1 - Department of Pharmacy, University of Claude Bernard Lyon 1 - Department of Medicine of Health Care Workers, University of Claude Bernard Lyon 1 - Medical Oncology Department, University of Claude Bernard Lyon 1 - Department of Pharmacy, University of Claude Bernard Lyon 1 - Medical Oncology Department, University of Claude Bernard Lyon 1 - Medical Oncology Department, University of Claude Bernard Lyon 1 - Medical Oncology Department, University of Claude Bernard Lyon 1 - Department DCSEI, University of Claude Bernard Lyon 1 - Department DCSEI, University of Claude Bernard Lyon 1 - Department of Surgery, University of Claude Bernard Lyon 1 - Medical Oncology Department, University of Claude Bernard Lyon 1 - Department of Hematology, University of Claude Bernard Lyon 1 - Department of Surgery, University of Claude Bernard Lyon 1 - Department of Clinical Research Centre, University of Claude Bernard Lyon 1 - Department of Clinical Research Centre and University of Claude Bernard Lyon 1 - Medical Oncology Department
Downloads 76 (837,727)

Abstract:

Loading...

Cancer, COVID-19, vaccination, risk factors, death

2.

Mortality of Patients with Cancer Presenting with Symptoms of COVID-19 With vs Without Detectable SARS-CoV-2: A Nationwide Prospective Cohort Study

Number of pages: 25 Posted: 08 Oct 2020
Souad Assaad, Philippe Zrounba, Claire Cropet, Charlotte Faucher, Bertrand Gachot, Anne Laure Simonet-Lamm, Stéphane Lepretre, Dominique Vanjak, Simon Pernot, Fadila Chergui, Laetitia Stefani, Jocelyne Provencal, Thibault Le Bourgeois, Xavier Durando, Julien Péron, Roland Schott, Guillaume Carbonnelle, Magali Briere, Blaha Belgadi, Adeline Debreuve, Marianne Hamon, Dominique Dramais, Philippe Rochigneux, Clemence Brac De La Perriere, Boris Campillo-Gimenez, Julien Gautier, Olivia Febvey-Combes, David Pérol, Jean-Yves Blay and The Investigators of the ONCOVID-19 Study
University of Claude Bernard Lyon 1 - Medical Oncology Department, University of Claude Bernard Lyon 1 - Department of Surgery, Centre Léon Berard - Department of Clinical Research and Innovation, Institut de Cancérologie de Montpellier, Gustave Roussy Villejuif, Centre Georges-François Leclerc, Centre Henri Becquerel, Institut Curie, Bergonié Institute, Institut de Cancérologie de Lorraine, CH Annecy-Genevois, Centre Hospitalier Métropole Savoie, Centre Antoine Lacassagne, Centre Jean Perrin, Institut de Cancérologie des Hospices Civils de Lyon - Centre Hospitalier Lyon-Sud, Institut de cancérologie Strasbourg Europe ICANS, Centre Oscar Lambret, Institut de Cancérologie de l'Ouest, Groupement Hospitalier Porte de Provence, Institut Jean Godinot, Centre François Baclesse, Centre hospitalier de Valence, Institut Paoli Calmettes, IUCT Oncopole - Institut Universitaire du Cancer de Toulouse, Centre Eugene Marquis, Centre Léon Berard - Department of Clinical Research and Innovation, Centre Léon Berard - Department of Clinical Research and Innovation, University of Claude Bernard Lyon 1 - Department of Clinical Research Centre, University of Claude Bernard Lyon 1 - Medical Oncology Department and Independent
Downloads 47 (1,109,210)

Abstract:

Loading...

Medical oncology, infectious disease, supportive care, COVID-19, Epidemiology, Morbidity/Mortality, Predictive factors.

3.

COVID-19 Vaccination Before Immune Checkpoint Inhibitor Initiation and the Overall Survival of Patients with Advanced Cancer

Number of pages: 11 Posted: 10 Jan 2026
Jean-Yves Blay, Pierre E. HEUDEL, Virginie Avrillon, Benedicte Mastroianni, Helene Boyle, Souad Assaad, Isabelle-Laure Ray-Coquard, Jean-Philippe Spano and Maurice Perol
University of Claude Bernard Lyon 1 - Medical Oncology Department, Institut d’Hématologie et d’Oncologie Pédiatrique (iHOPe) - Centre Léon Bérard, University of Claude Bernard Lyon 1 - Medical Oncology Department, affiliation not provided to SSRN, University of Claude Bernard Lyon 1 - Centre Léon Bérard, University of Claude Bernard Lyon 1 - Medical Oncology Department, University of Claude Bernard Lyon 1 - Medical Oncology Department, affiliation not provided to SSRN and University of Claude Bernard Lyon 1 - Centre Léon Bérard
Downloads 35 (1,304,549)

Abstract:

Loading...

COVID-19, Vaccination, Cancer, immune checkpoint inhibitor, PD1, Survival